11/13/2026 | Press release | Distributed by Public on 11/13/2026 07:12
|
Three months ended
|
|||||||||||||||||||||||
|
June 30, 2026
|
March 31, 2026
|
June 30, 2025
|
March 31, 2025
|
||||||||||||||||||||
|
Net sales
|
$
|
366,290
|
$
|
395,153
|
$
|
344,557
|
$
|
384,956
|
|||||||||||||||
|
Cost of sales
|
309,522
|
337,078
|
292,034
|
329,458
|
|||||||||||||||||||
|
Gross profit
|
56,768
|
58,075
|
52,523
|
55,498
|
|||||||||||||||||||
|
Selling, general, and administrative expenses
|
44,558
|
44,235
|
44,968
|
42,984
|
|||||||||||||||||||
|
Research and development expenses
|
3,711
|
3,159
|
2,805
|
2,830
|
|||||||||||||||||||
|
Royalty expense
|
2,653
|
2,410
|
2,419
|
2,446
|
|||||||||||||||||||
|
Restructuring and other charges
|
834
|
25,142
|
-
|
-
|
|||||||||||||||||||
|
Income (loss) from operations
|
5,012
|
(16,871)
|
2,331
|
7,238
|
|||||||||||||||||||
|
Interest expense
|
(10,054)
|
(9,887)
|
(9,674)
|
(9,534)
|
|||||||||||||||||||
|
Interest income
|
2,317
|
1,898
|
2,094
|
1,950
|
|||||||||||||||||||
|
Foreign exchange loss
|
(75)
|
(321)
|
(1,969)
|
(819)
|
|||||||||||||||||||
|
Other income
|
506
|
756
|
993
|
697
|
|||||||||||||||||||
|
Loss from continuing operations before income taxes
|
(2,294)
|
(24,425)
|
(6,225)
|
(468)
|
|||||||||||||||||||
|
(Benefit) provision for income taxes
|
(1,032)
|
3,304
|
621
|
3,368
|
|||||||||||||||||||
|
Net loss from continuing operations
|
(1,262)
|
(27,729)
|
(6,846)
|
(3,836)
|
|||||||||||||||||||
|
Net income from discontinued operations, net of tax
|
7,602
|
3,479
|
3,242
|
3,858
|
|||||||||||||||||||
|
Net income (loss)
|
6,340
|
(24,250)
|
(3,604)
|
22
|
|||||||||||||||||||
|
Net income (loss) attributable to noncontrolling interests
|
576
|
(36)
|
941
|
671
|
|||||||||||||||||||
|
Net income (loss) attributable to Titan and applicable to common shareholders
|
$
|
5,764
|
$
|
(24,214)
|
$
|
(4,545)
|
$
|
(649)
|
|||||||||||||||
|
(Loss) earnings per common share:
|
|||||||||||||||||||||||
|
Basic net loss from continuing operations per share
|
$
|
(0.02)
|
$
|
(0.43)
|
$
|
(0.11)
|
$
|
(0.06)
|
|||||||||||||||
|
Basic net income (loss) per share attributable to Titan and applicable common stockholders
|
$
|
0.09
|
$
|
(0.38)
|
$
|
(0.07)
|
$
|
(0.01)
|
|||||||||||||||
|
Diluted net loss from continuing operations per share
|
$
|
(0.02)
|
$
|
(0.43)
|
$
|
(0.11)
|
$
|
(0.06)
|
|||||||||||||||
|
Diluted net income (loss) per share attributable to Titan and applicable common stockholders
|
$
|
0.09
|
$
|
(0.38)
|
$
|
(0.07)
|
$
|
(0.01)
|
|||||||||||||||
|
Average common shares and equivalents outstanding:
|
|||||||||||||||||||||||
|
Basic
|
64,384
|
64,072
|
63,722
|
63,283
|
|||||||||||||||||||
|
Diluted
|
64,504
|
64,072
|
63,722
|
63,283
|
|||||||||||||||||||
|
Three months ended
|
|||||||||||||||||||||||
|
Cash flows from operating activities:
|
June 30, 2026
|
March 31, 2026
|
June 30, 2025
|
March 31, 2025
|
|||||||||||||||||||
|
Net income (loss)
|
$
|
6,340
|
$
|
(24,250)
|
$
|
(3,604)
|
$
|
22
|
|||||||||||||||
|
Net income from discontinued operations, net of tax
|
7,602
|
3,479
|
3,242
|
3,858
|
|||||||||||||||||||
|
Net loss from continuing operations
|
(1,262)
|
(27,729)
|
(6,846)
|
(3,836)
|
|||||||||||||||||||
|
Adjustments to reconcile net loss to net cash provided by operating activities of continuing operations:
|
|||||||||||||||||||||||
|
Depreciation and amortization
|
13,702
|
13,592
|
13,443
|
12,868
|
|||||||||||||||||||
|
Restructuring and other charges
|
834
|
25,142
|
-
|
-
|
|||||||||||||||||||
|
Deferred income tax (benefit) provision
|
(4,838)
|
1,155
|
3,379
|
(1,201)
|
|||||||||||||||||||
|
(Gain) loss on fixed asset and investment sale
|
(20)
|
64
|
(2)
|
40
|
|||||||||||||||||||
|
Stock-based compensation
|
1,221
|
565
|
1,405
|
(925)
|
|||||||||||||||||||
|
Issuance of stock under 401(k) plan
|
420
|
418
|
431
|
396
|
|||||||||||||||||||
|
Foreign currency (gain) loss
|
(1,217)
|
1,464
|
14,367
|
3,180
|
|||||||||||||||||||
|
(Increase) decrease in assets:
|
|||||||||||||||||||||||
|
Accounts receivable
|
24,481
|
(84,724)
|
35,047
|
(78,735)
|
|||||||||||||||||||
|
Inventories
|
3,222
|
7,736
|
(12,895)
|
(2,318)
|
|||||||||||||||||||
|
Prepaid and other current assets
|
(1,826)
|
955
|
(2,759)
|
(359)
|
|||||||||||||||||||
|
Other assets
|
(2,912)
|
(3,245)
|
(2,961)
|
(1,417)
|
|||||||||||||||||||
|
Increase in liabilities:
|
|||||||||||||||||||||||
|
Accounts payable
|
(6,162)
|
17,671
|
(19,760)
|
39,282
|
|||||||||||||||||||
|
Other current liabilities
|
1,986
|
5,903
|
(9,067)
|
106
|
|||||||||||||||||||
|
Other liabilities
|
2,626
|
569
|
1,658
|
410
|
|||||||||||||||||||
|
Net cash provided by (used for) operating activities of continuing operations
|
30,255
|
(40,464)
|
15,440
|
(32,509)
|
|||||||||||||||||||
|
Net cash provided by (used for) operating activities of discontinued operations
|
8,894
|
(6,062)
|
(1,127)
|
(6,082)
|
|||||||||||||||||||
|
Net cash provided by (used for) operating activities
|
39,149
|
(46,526)
|
14,313
|
(38,591)
|
|||||||||||||||||||
|
Cash flows from investing activities:
|
|||||||||||||||||||||||
|
Capital expenditures
|
(8,628)
|
(10,397)
|
(8,697)
|
(13,503)
|
|||||||||||||||||||
|
Proceeds (loss) from sale of fixed assets
|
843
|
(25)
|
29
|
182
|
|||||||||||||||||||
|
Net cash used for investing activities of continuing operations
|
(7,785)
|
(10,422)
|
(8,668)
|
(13,321)
|
|||||||||||||||||||
|
Net cash used for investing activities of discontinued operations
|
(4,081)
|
(2,712)
|
(1,350)
|
(1,507)
|
|||||||||||||||||||
|
Net cash used for investing activities
|
(11,866)
|
(13,134)
|
(10,018)
|
(14,828)
|
|||||||||||||||||||
|
Cash flows from financing activities:
|
|||||||||||||||||||||||
|
Proceeds from borrowings
|
17,362
|
57,698
|
28,327
|
26,604
|
|||||||||||||||||||
|
Repayments of debt
|
(35,890)
|
(32,686)
|
(29,335)
|
(6,496)
|
|||||||||||||||||||
|
Other financing activities
|
(22)
|
(195)
|
(133)
|
98
|
|||||||||||||||||||
|
Net cash (used for) provided by financing activities of continuing operations
|
(18,550)
|
24,817
|
(1,141)
|
20,206
|
|||||||||||||||||||
|
Net cash (used for) provided by financing activities of discontinued operations
|
(889)
|
1,377
|
(567)
|
(1,592)
|
|||||||||||||||||||
|
Net cash (used for) provided by financing activities
|
(19,439)
|
26,194
|
(1,708)
|
18,614
|
|||||||||||||||||||
|
Effect of exchange rate changes on cash
|
679
|
1,849
|
7,652
|
13,261
|
|||||||||||||||||||
|
Net increase (decrease) in cash and cash equivalents
|
8,523
|
(31,617)
|
10,239
|
(21,544)
|
|||||||||||||||||||
|
Cash and cash equivalents, beginning of period
|
171,262
|
202,879
|
174,430
|
195,974
|
|||||||||||||||||||
|
Cash and cash equivalents, end of period
|
$
|
179,785
|
$
|
171,262
|
$
|
184,669
|
$
|
174,430
|
|||||||||||||||
|
Supplemental information:
|
|||||||||||||||||||||||
|
Interest paid
|
$
|
17,260
|
$
|
3,396
|
$
|
17,959
|
$
|
3,209
|
|||||||||||||||
|
Income taxes paid, net of refunds received
|
4,299
|
2,137
|
4,714
|
3,421
|
|||||||||||||||||||
|
Three months ended
|
|||||||||||||||||||||||
|
June 30, 2026
|
March 31, 2026
|
June 30, 2025
|
March 31, 2025
|
||||||||||||||||||||
|
Net loss from continuing operations
|
$
|
(1,262)
|
$
|
(27,729)
|
$
|
(6,846)
|
$
|
(3,836)
|
|||||||||||||||
|
Adjustments:
|
|||||||||||||||||||||||
|
(Benefit) provision for income taxes
|
(1,032)
|
3,304
|
621
|
3,368
|
|||||||||||||||||||
|
Interest expense, excluding financing fees amortization
|
9,897
|
9,972
|
9,759
|
9,592
|
|||||||||||||||||||
|
Depreciation and amortization
|
13,702
|
13,592
|
13,443
|
12,868
|
|||||||||||||||||||
|
EBITDA from continuing operations
|
$
|
21,305
|
$
|
(861)
|
$
|
16,977
|
$
|
21,992
|
|||||||||||||||
|
Adjustments:
|
|||||||||||||||||||||||
|
Foreign exchange loss
|
75
|
321
|
1,969
|
819
|
|||||||||||||||||||
|
Restructuring and impairment expenses
|
834
|
25,142
|
-
|
-
|
|||||||||||||||||||
|
Adjusted EBITDA from continuing operations
|
$
|
22,214
|
$
|
24,602
|
$
|
18,946
|
$
|
22,811
|
|||||||||||||||
|
Adjusted EBITDA from discontinued operations
|
11,946
|
6,754
|
11,213
|
8,012
|
|||||||||||||||||||
|
Adjusted EBITDA attributable to Titan and applicable to common shareholders
|
$
|
34,160
|
$
|
31,356
|
$
|
30,159
|
$
|
30,823
|
|||||||||||||||